Standout Papers
Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage
2008
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage
2008
Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
2011
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
2015
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
2007
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study
2006
Pathogens Isolated From Deep Soft Tissue and Bone in Patients With Diabetic Foot Infections
2008
The Diabetic Person Beyond a Foot Ulcer
2008
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients
2014
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
MANAGEMENT OF DIABETIC FOOT INFECTIONS, INCLUDING THE USE OF HOME INTRAVENOUS ANTIBIOTIC THERAPY
1996
Recombinant Factor VIIa for Rapid Reversal of Warfarin Anticoagulation in Acute Intracranial Hemorrhage
2004
Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules
2011
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT
1988
Prosthetic Heart Valves
1996
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
2016
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
Can Aggressive Treatment of Diabetic Foot Infections Reduce the Need for Above-Ankle Amputation?
1996
Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement?
2004
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
2007
Intracerebral haemorrhage
2009 Standout
Evidence-Based Management of Anticoagulant Therapy
2012
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Cerebral microbleeds: a guide to detection and interpretation
2009 Standout
Performance Improvement in the Management of Sepsis
2009
The controversy of managing calf vein thrombosis
2011
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015
Magnetic Resonance Imaging for Diagnosing Foot Osteomyelitis
2007
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
2012
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
2008
Warfarin reversal
2004
MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength
2008
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
2012
Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage
2008
New Antithrombotic Drugs
2012
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group
2004
Antithrombotic Therapy for VTE Disease
2016 Standout
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology
2004 Standout
Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms
2006
Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage
2011
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
2007
Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients
2017
Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke
1998
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
2002
Lyme Disease
2001
Cost-effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
2000
Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage
2012
A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
1990
Severe Sepsis and Septic Shock
2013 Standout
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
2000
Can Selected Patients With Newly Diagnosed Pulmonary Embolism Be Safely Treated Without Hospitalization? A Systematic Review
2012
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
2012
Prolonged Emergency Department Length of Stay is not Associated with Worse Outcomes in Patients with Intracerebral Hemorrhage
2011
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
2001
Location and Outcome of Anticoagulant-Associated Intracerebral Hemorrhage
2006
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
2003
Catheter-Related Thrombosis in Cancer Patients: Pathophysiology, Diagnosis, and Management
2005
Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
2013
Antithrombotic Therapy for VTE Disease
2012 Standout
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
2005
Antiplatelet Drugs
2012
Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation
2013
Recurrent Stroke after Lobar and Deep Intracerebral Hemorrhage: A Hospital-Based Cohort Study
2011
Executive Summary
2012 Standout
Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients
2012
Atrial fibrillation
2011
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2012
Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers
2008
Medical literature, vena cava filters and evidence of efficacy
2013
Accuracy of CT angiography for the diagnosis of vascular abnormalities causing intraparenchymal hemorrhage in young patients
2009
Statins and Intracerebral Hemorrhage
2011
Diabetic foot ulcers
2003 Standout
Antithrombotic Therapy in Atrial Fibrillation
2004
Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages
2007
Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
2006
‘Sausage toe’: a reliable sign of underlying osteomyelitis
2000
Therapy for Lyme arthritis: Strategies for the treatment of antibiotic‐refractory arthritis
2006
The Perioperative Management of Antithrombotic Therapy
2008
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Outcome of Noncardiac and Nonvascular Surgery in Patients With Mechanical Heart Valves
2012
Outcome of Diabetic Foot Infections Treated Conservatively
1999
Health-related quality of life in patients with diabetes mellitus and foot ulcers
2000
Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness
2007
Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge*
1999
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Validation of Clinical Prediction Scores in Patients with Primary Intracerebral Hemorrhage
2013
Reinitiation of Anticoagulation After Warfarin-Associated Intracranial Hemorrhage and Mortality Risk: The Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) Study
2011
Primary and Secondary Prevention of Cardiovascular Disease
2012
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Antithrombotic Therapy in Neonates and Children
2012
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome
2004
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Diagnostic Accuracy of the Physical Examination and Imaging Tests for Osteomyelitis Underlying Diabetic Foot Ulcers: Meta‐Analysis
2008
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Transmission and Institutional Infection Control of Tuberculosis
2015
The risk of recurrent stroke after intracerebral haemorrhage
2007
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia
1999
Early Lyme Disease
2006
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
2009
Triple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
2013
Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis
1999
Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial
2000
Costs of Deep Foot Infections in Patients with Diabetes Mellitus
2000
Antithrombotic and Thrombolytic Therapy for Valvular Disease
2012
The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning
2006
Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin
2013
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Prophylactic Antiepileptic Drug Use is Associated with Poor Outcome Following ICH
2009
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
2011
Determinants of Outcome in Anticoagulation-Associated Cerebral Hematoma Requiring Emergency Evacuation
2006
Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset
2016
Antithrombotic Therapy in Atrial Fibrillation
2008
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention
2012
Controversies in Diagnosing and Managing Osteomyelitis of the Foot in Diabetes
2004
Adherence to Medication
2005 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
2016
Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty
2001
Warfarin use leads to larger intracerebral hematomas
2008
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2018
Cardiac causes of stroke
2000
Antiplatelet use after intracerebral hemorrhage
2006
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease
2000
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Statin Therapy and the Risk of Intracerebral Hemorrhage
2012
Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
1989
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
2011
Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage
2006
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy
2005
Cerebral Microhemorrhage
2006
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA 2 DS 2 -VASc Risk Factor Be Anticoagulated?
2016
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Users' Guides to the Medical Literature
1993
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
2018
Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications
2014
Systems to rate the strength of scientific evidence.
2002
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
2004
Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage
2005
Prosthetic heart valves and anticoagulant management during non-cardiac surgery
1995
Antiretroviral adherence interventions: a review of current literature and ongoing studies.
2004
Statin Use and Microbleeds in Patients With Spontaneous Intracerebral Hemorrhage
2012
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The Genetic Architecture of Intracerebral Hemorrhage
2008
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
2010
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Status of Antithrombotic Therapy for Patients With Atrial Fibrillation in University Hospitals
1996
Prophylaxis for Deep Venous Thrombosis in Craniotomy Patients: A Decision Analysis
2005
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
2004
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
2007
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage
2007
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy
2005
CT Angiography for Intracerebral Hemorrhage Does Not Increase Risk of Acute Nephropathy
2009
Outcome of Diabetic Foot Osteomyelitis Treated Nonsurgically
2008
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
2016
Warfarin therapy: evolving strategies in anticoagulation.
1999
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
2007
Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation
2016
Predicting Readmission Stroke Type Among Blacks and Whites in California
2005
Diagnosis and Treatment of Diabetic Foot Infections
2004
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
2010
Long-term mortality after intracerebral hemorrhage
2006
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
2006
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
2005
Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy
2006
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
2012
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
2016
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
2004
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
2010
Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage
2011
Airborne transmission of respiratory viruses
2021 StandoutScience
Supplement to the Guidelines for the Management of Transient Ischemic Attacks
1999
Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database
2008
Works of Mark H. Eckman being referenced
Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin
2005
A Decision Analytic View of Anticoagulant Prophylaxis for Thromboembolism in Heart Disease
1989
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
1998
Antithrombotic Therapy in Valvular Heart Disease
1998
Perioperative Management of Antithrombotic Therapy
2012 Standout
The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage
2004
Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis
2002
Grades of Recommendation for Antithrombotic Agents
1998
Warfarin for Dilated Cardiomyopathy
1989
Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness Issues
1998
Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states
1993
Making Decisions About Antithrombotic Therapy in Heart Disease
1995
Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia
1999
Statin Use Following Intracerebral Hemorrhage
2011
The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants
2002
Application of a Decision Support Tool for Anticoagulation in Patients with Non-valvular Atrial Fibrillation
2008
Decision Analytic and Cost-Effectiveness Issues Concerning Anticoagulant Prophylaxis in Heart Disease
1992
Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care Workers
2009
Cost Effectiveness of Oral as Compared with Intravenous Antibiotic Therapy for Patients with Early Lyme Disease or Lyme Arthritis
1997
Antithrombotic Therapy for Atrial Fibrillation
2012
Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines
2012
Antithrombotic Therapy in Valvular Heart Disease
2001
Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset Nonvalvular Atrial Fibrillation
2003
Radioiodine or Surgery for Toxic Thyroid Adenoma: Dissecting an Important Decision. A Cost-Effectiveness Analysis
2004
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
1993
Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation
2014
Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis
2002
Antithrombotic Therapy in Valvular Heart Disease
1995
Foot Infections in Diabetic Patients
1995
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves
1990
A Decision Analytic View of Anticoagulant Prophylaxis for Thromboembolism in Heart Disease
1986
Moving the Tipping Point
2010
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation
2008
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?
2003
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
2009